Role of Alternative Medical Systems in Adult Chronic Kidney Disease Patients: A Systematic Review of Literature

Linda Rider

Chronic kidney disease (CKD) is one of the leading causes of death globally, which affects 13.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of the world’s population [1]. With deterioration in renal function, this leads to the onset of CKD-related complications, such as uremia, anemia, and electrolyte disorders [2]. These complications often manifest as symptoms ranging from pruritus, pain, and […]

FDA investigating risk of severe hypocalcemia in patients on dialysis receiving osteoporosis medicine Prolia (denosumab)

Linda Rider

Drug Safety Conversation (PDF – 166 KB) 11-22-2022 Fda Drug Safety Interaction The U.S. Foodstuff and Drug Administration (Fda) is investigating the threat of intense hypocalcemia with critical outcomes, such as hospitalization and demise, in clients with superior kidney disorder on dialysis treated with the osteoporosis drugs Prolia (denosumab). Our […]